HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Up-regulation of brain-enriched miR-107 promotes excitatory neurotoxicity through down-regulation of glutamate transporter-1 expression following ischaemic stroke.

Abstract
Recent studies have uncovered that accumulation of glutamate after ischaemic stroke is closely associated with the down-regulation of glutamate transporter-1 (GLT-1) expression, suggesting that GLT-1 expression critically controls glutamate accumulation and the abnormal glutamate transport-elicited neuronal cell excitotoxicity in patients with ischaemic stroke. However, it remains unknown how GLT-1 expression is regulated under ischaemic stroke conditions. In the present study, we screened the expression of nine brain-specific or brain-enriched miRNAs in a focal cerebral ischaemia/reperfusion (I/R) injury rat model, which showed glutamate accumulation and down-regulated GLT-1 expression as expected, and revealed that the miR-107 level was elevated in both brain tissue and plasma in the model. Next, we examined the functional relationship of miR-107 with GLT-1 expression in a nerve cell hypoxia/reoxygenation (H/R) injury model. H/R treatment increased apoptosis of the nerve cells concomitant with glutamate accumulation, miR-107 elevation and suppressed GLT-1 expression, mimicking our in vivo findings in the cerebral I/R injury rat model in vitro. Co-treating the cells with an miR-107 inhibitor blocked all of the effects, demonstrating that miR-107 functions to inhibit GLT-1 expression and elevate glutamate accumulation. To extend these animal and cell-based studies to clinical patients, we measured the plasma levels of miR-107 and glutamate, and observed that both miR-107 and glutamate were elevated in patients with ischaemic stroke. On the basis of these observations, we conclude that elevated miR-107 expression after ischaemic stroke accounts, at least partially, for glutamate accumulation through suppression of GLT-1 expression. Our findings also highlight that the plasma level of miR-107 may serve as a novel biomarker for monitoring excitotoxicity in patients with ischaemic stroke.
AuthorsZhong-Bao Yang, Zhen Zhang, Ting-Bo Li, Zheng Lou, Shu-Yu Li, Huan Yang, Jie Yang, Xiu-Ju Luo, Jun Peng
JournalClinical science (London, England : 1979) (Clin Sci (Lond)) Vol. 127 Issue 12 Pg. 679-89 (Dec 2014) ISSN: 1470-8736 [Electronic] England
PMID24943094 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Excitatory Amino Acid Transporter 2
  • MIRN107 microRNA, human
  • MIRN107 microRNA, rat
  • MicroRNAs
  • RNA, Antisense
  • Glutamic Acid
Topics
  • Animals
  • Apoptosis
  • Brain (metabolism)
  • Brain Ischemia (genetics, metabolism, pathology)
  • Cell Hypoxia (genetics)
  • Down-Regulation
  • Excitatory Amino Acid Transporter 2 (genetics, metabolism)
  • Female
  • Glutamic Acid (metabolism)
  • Humans
  • Male
  • MicroRNAs (antagonists & inhibitors, blood, metabolism, physiology)
  • Middle Aged
  • RNA Interference
  • RNA, Antisense (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Stroke (genetics, metabolism, pathology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: